Asharqia Chamber presents you with its best regards and informs you that it has received the letter of the Council of Saudi Chambers No. (KG / 929) and the date (04/25/1441 AH), referred to in the Food and Drug Authority’s letter number (13348 / p) and the date (04/21/1441 AH) This includes announcing the start of the application of the electronic tracking system for pharmaceutical preparations “monitoring” and circular No. (46108 / p) and the date of (8/6/1440 AH), which includes the confirmation of the use of a monitoring system and determining the time limit for the application of the principle of aggregation and where the authority wishes to confirm As follows:
It is mandatory to register in a monitoring system and use it to report operations by all agencies involved in drug operations (manufacturing, importing, storing, distributing, selling or consuming) since the date (1/7/2019).
Take note of the extension of the time limit for integration with the system for monitoring and applying the principle of aggregation until the date of 3/31/2020, with the need to comply during this period for all the operations that are carried out on the medicine package through the system.
The authority also reports the completion of integration with a monitoring system before the date indicated above, and for more information and support in that, you can contact the authority's email (RSD@lean.sa) or phone (0114866803).
